Abstract
Previous studies have demonstrated that cell populations that are cultured with heterologous animal products can acquire xenoantigens, potentially limiting their clinical utility because of immune responses. Embryonic stem cells (ESCs) are an attractive source of multiple potential cellular therapies and are typically derived and routinely cultured on murine embryonic fibroblast (MEFs) feeder cell layers in commercially available serum replacement (SR) medium or fetal calf serum (FCS) containing medium. Recently we found that a strong antibody response was generated in human subjects after the second infusion of therapeutic cells cultured in FCS containing medium. This response was specific for bovine apolipoprotein B‐100 (apoB‐100) which is the major protein component of LDL and targets its binding to abundant low density lipoprotein receptors on the cell surface from which it is internalized. Here we have shown that ESCs cultured on MEFs in SR medium acquired bovine apoB‐100 from MEFs and from the SR medium as well. Our findings also suggest that bovine low density lipoproteins (LDL) are used as critical nutrients for ESC propagation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
